Key result
Successful CTO-PCI linked to improved 1-year survival vs failed PCI, with an ~11% high-risk mortality difference.
Why the study?
PCI is widely used in patients with CTO, but its benefit in improving long-term outcomes remains controversial.
Does successful CTO-PCI improve one-year mortality compared to failed CTO-PCI in patients with chronic total occlusion?
Observational (n=2,625)
Yes
Does successful CTO-PCI improve one-year mortality compared to failed CTO-PCI in patients with chronic total occlusion?
Answers are grounded in this paper and cite their sources.
A novel scoring system (HABARA score) incorporating diabetes, angina severity, multivessel disease, and prior MI can predict the survival advantage of successful versus failed CTO-PCI, aiding in preprocedural decision-making.
Background: Percutaneous coronary intervention (PCI) is widely used in patients with chronic total occlusion (CTO), but its benefit in improving long-term outcomes is controversial. We aimed to develop a prediction score for grading “survival advantage” conferred by successful results of CTO-PCI and a scoring system for prediction of the influence of CTO-PCI results on major adverse cardiac and cerebrovascular events (MACCEs). Methods: Follow-up data of 2625 patients who underwent CTO-PCI at 65 Japanese centers were analyzed. An integer scoring system was developed by including statistical effect modifiers on the association between successful CTO-PCI and one-year mortality. Results: Follow-up at 12 months was completed in 2034 patients. During follow-up, 76 deaths (3.7%) occurred. Patients with successful CTO-PCI had a better one-year survival than patients with failed CTO-PCI (log rank P = 0.016). Effect modifiers for the association between successful procedure and one-year mortality included diabetes (P interaction = 0.043), multivessel disease (P interaction = 0.175), Canadian Cardiovascular Society class ≥2 (P interaction = 0.088), and prior myocardial infarction (MI) (P interaction = 0.117). Each component was assigned a single point and summed to develop the scoring system. The patients were then categorized to specify the prediction of survival advantage by successful PCI: ≤2 (normal) and ≥3 (distinct). The differences in one-year mortality between patients with successful and failed treatment were −0.7% and 11.3% for normal and distinct score categories, respectively. In the scoring system for MACCE, score components were prior MI (P interaction = 0.19), left anterior descending artery (LAD)-CTO (P interaction = 0.079), and reattempt of CTO-PCI (P interaction = 0.18). The differences in one-year MACCEs between successful and failed patients for each score category (0, 1, and ≥2) were −1.7%, 7.5%, and 15.1%, respectively. Conclusions: The novel scoring system assessing the advantage of successful PCI can be easily applied in patients with CTO. It is a valid instrument for clinical decision-making while assessing the survival advantage of CTO-PCI and the influence of procedural results on MACCEs.
No takes yet. Share an insight, caveat, or question.
Nakachi et al. (2020) conducted an observational in Chronic total occlusion (CTO) (n=2,625). Successful percutaneous coronary intervention vs. Failed percutaneous coronary intervention was evaluated on One-year all-cause mortality (p=0.016). Successful percutaneous coronary intervention for chronic total occlusion improved 1-year survival compared to failed procedures, with a novel scoring system identifying a distinct 11.3% mortality difference in high-risk patients.
Synapse has enriched 10 related papers. Consider them for comparative context: